The Expression of CXCL10/CXCR3 and Effect of the Axis on the Function of T Lymphocyte Involved in Oral Lichen Planus

被引:19
|
作者
Fang, Jiaxiang [1 ,2 ]
Wang, Chen [1 ,2 ]
Shen, Chen [3 ]
Shan, Jing [1 ,2 ]
Wang, Xuewei [1 ,2 ]
Liu, Lin [1 ,2 ]
Fan, Yuan [1 ,2 ]
机构
[1] Nanjing Med Univ, Jiangsu Key Lab Oral Dis, Nanjing 210029, Jiangsu, Peoples R China
[2] Nanjing Med Univ, Affiliated Hosp Stomatol, Dept Oral Med, 136 Hanzhong Rd, Nanjing 210029, Jiangsu, Peoples R China
[3] Hangzhou West Dent Hosp, Dept Special Outpatient Serv, Hangzhou 310012, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
CXCR3; CXCL10; oral lichen planus; chemokine; CHEMOKINE RECEPTOR CXCR3; CELLS; RECRUITMENT; APOPTOSIS; MIGRATION; LIGANDS; BLOOD; CXCL9;
D O I
10.1007/s10753-018-0934-0
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The etiology of oral lichen planus (OLP) is still not clear. The purpose of this study was to explore the role of CXC chemokine receptor 3(CXCR3) and its ligand CXC motif chemokine 10(CXCL10) in the pathogenesis of OLP. We examined the expression of CXCR3 and CXCL10 in OLP patients and healthy controls by quantitative real-time PCR, Western blotting, ELISAs, and immunohistochemistry, respectively. Moreover, we detected the effects of CXCL10/CXCR3 axis on T lymphocyte migration, proliferation and apoptosis by Transwell assays, CCK8 assays, and flow cytometry. We found that the expression of CXCR3 and CXCL10 was significantly increased in OLP patients. In addition, T lymphocyte migration rate of CXCL10 stimulation group was significantly higher than that of control and CXCR3 antagonist groups. After antagonizing CXCR3, the migration ability of T lymphocytes was significantly decreased, and regardless of whether CXCL10 was added in the upper chamber culture medium, the number of migrating cells was similar. The addition of CXCL10 stimulant could stimulate the proliferation of T lymphocytes, but there was no significant difference compared with control group. After antagonizing CXCR3, the proliferation rate of T lymphocytes was significantly reduced. However, there were no significant differences in the apoptosis rates of T lymphocytes between CXCL10 stimulation group, antagonist CXCR3 group, and control group. Due to the change of expression in CXCR3 and CXCL10, and its interaction in mediating the directional migration of peripheral blood T lymphocytes, affecting the proliferation of T lymphocytes, it suggests that CXCL10/CXCR3 axis may be related to the immune mechanism of OLP.
引用
收藏
页码:799 / 810
页数:12
相关论文
共 50 条
  • [21] Neuronal CXCL10/CXCR3 Axis Mediates the Induction of Cerebral Hyperexcitability by Peripheral Viral Challenge
    Petrisko, Tiffany J.
    Bloemer, Jenna
    Pinky, Priyanka D.
    Srinivas, Sriraja
    Heslin, Ryan T.
    Du, Yifeng
    Setti, Sharay E.
    Hong, Hao
    Suppiramaniam, Vishnu
    Konat, Gregory W.
    Reed, Miranda N.
    FRONTIERS IN NEUROSCIENCE, 2020, 14
  • [22] Involvement of the CXCL10/CXCR3 axis in the mechanism responsible for cutaneous reverse passive Arthus reaction
    Noda, S.
    Asano, Y.
    Tada, Y.
    Sugaya, M.
    Kadono, T.
    Sato, S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2011, 131 : S2 - S2
  • [23] Cancer cells reduce macrophage CXCR3/CXCL10 axis expression through canonical NF-κB signaling
    Korkaya, Ahmet K.
    Bradford, Jennifer W.
    CANCER IMMUNOLOGY RESEARCH, 2022, 10 (12)
  • [24] CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy
    Tokunaga, Ryuma
    Zhang, Wu
    Naseem, Madiha
    Puccini, Alberto
    Berger, Martin D.
    Soni, Shivani
    McSkane, Michelle
    Baba, Hideo
    Lenz, Heinz-Josef
    CANCER TREATMENT REVIEWS, 2018, 63 : 40 - 47
  • [25] STAT3 in CD8+ T Cells Inhibits Their Tumor Accumulation by Downregulating CXCR3/CXCL10 Axis
    Yue, Chanyu
    Shen, Shudan
    Deng, Jiehui
    Priceman, Saul J.
    Li, Wenzhao
    Huang, Austin
    Yu, Hua
    CANCER IMMUNOLOGY RESEARCH, 2015, 3 (08) : 864 - 870
  • [26] CXCL9, CXCL10, CXCL11, and their receptor (CXCR3) in neuroinflammation and neurodegeneration
    Koper, Olga M.
    Kaminska, Joanna
    Sawicki, Karol
    Kemona, Halina
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 27 (06): : 849 - 856
  • [27] CXCR3 and heparin binding sites of the chemokine IP-10 (CXCL10)
    Campanella, GSV
    Lee, EMJ
    Sun, J
    Luster, AD
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (19) : 17066 - 17074
  • [28] Critical Role for the CXCL10/CXCR3 Axis in Leukocyte Recruitment and Neuronal Injury in Traumatic Optic Neuropathy
    Ha, Yonju
    Liu, Hua
    Zhu, Shuang
    Nathanson, Jared
    Hu, Xiaobing
    Tilton, Ronald G.
    Motamedi, Massoud
    Zhang, Wenbo
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [29] Prognostic significance of CXCL10/CXCR3 overexpression in mucinous bronchioloalveolar carcinoma
    Duruisseaux, Michael
    Antoine, Martine
    Rabbe, Nathalie
    Poulot, Virginie
    Leprieur, Etienne Giroux
    Lavoie, Armelle
    Cadranel, Jacques
    Wislez, Marie
    CLINICAL CANCER RESEARCH, 2012, 18 (03)
  • [30] CXCL10/CXCR3 Signaling in the DRG Exacerbates Neuropathic Pain in Mice
    Yan-Fang Kong
    Wei-Lin Sha
    Xiao-Bo Wu
    Lin-Xia Zhao
    Ling-Jie Ma
    Yong-Jing Gao
    Neuroscience Bulletin, 2021, 37 (03) : 339 - 352